Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | SLC27A2 |
| Upstream (Parents) |
|---|
| (<<) ADH6 → SLC27A2 |
| (<<) EHHADH → SLC27A2 |
| Downstream (Children) |
|---|
| SLC27A2 → HIBCH (>>) |
| SLC27A2 → CCDC68 (>>) |
| SLC27A2 → ELOVL6 (>>) |
| SLC27A2 → SORD (>>) |
| SLC27A2 → LACTB2 (>>) |
| SLC27A2 → CBR4 (>>) |
| SLC27A2 → SC5DL (>>) |
| SLC27A2 → CPT2 (>>) |
| SLC27A2 → SALL1 (>>) |
| SLC27A2 → SHBG (>>) |
| SLC27A2 → CLGN (>>) |
| SLC27A2 → DBH (>>) |
| SLC27A2 → EHHADH (>>) |
| SLC27A2 → C2orf72 (>>) |
| SLC27A2 → RALGDS (>>) |
| SLC27A2 → BCKDHB (>>) |
| SLC27A2 → CYP2J2 (>>) |
